Adrenal anatomy and the work-up of hypercortisolism, hyperaldosteronism, phaeochromocytoma, adrenal insufficiency, and adrenal masses — including adrenal vein sampling, pre-operative blockade, and adrenocortical carcinoma.
Risk factors, genetics, staging, and management of non-muscle-invasive and muscle-invasive urothelial bladder cancer — including intravesical agent comparison, BCG schedule and toxicity, cystectomy technique and lymph node dissection boundaries.
Screening, biopsy, Gleason assignment, risk stratification, and treatment from localised to castration-resistant prostate cancer — including radical prostatectomy technique and complications, radiotherapy, and ADT pharmacology.
Risk factors, tumour markers, staging, and management of germ-cell and other testicular tumours — including RPLND technique and complications, post-chemotherapy residual masses, and paratesticular tumours.
Urolithiasis high-yield — stone types, metabolic work-up, dietary/medical prevention, dissolution therapy, and SWL vs URS vs PCNL selection with access technique and complications.
BPH high-yield — LUTS classification, IPSS, urodynamic formulae (BOOI/BCI), the management algorithm, medical therapy by predominant symptom, surgical choice by prostate size, the outcomes comparison table, and TURP complications including TUR syndrome and severe bleeding.
Female pelvic floor high-yield — DeLancey's support levels and POP-Q, prolapse management by compartment with the apex always supported, the female SUI pathway from the four mandatory investigations to the four unranked operations, urogenital fistula localization and repair, and the female urethral diverticulum.
Male SUI high-yield — ISD and the causes of incontinence after prostate treatment, natural history, pad-weight severity bands, the pre-surgical assessment, management by severity, the perineal male sling and its failure pathway, and AUS components, indications, contraindications, technique, retention, recurrence and complications.
Urodynamics high-yield — indications and the PFS thresholds, the 9 Cs, uroflowmetry pattern recognition, cystometry and compliance, ALPP vs DLPP, BOOI/BCI bands, EMG and DESD, the six dangerous findings, and videourodynamics.
Male factor infertility — physiology, semen analysis, hormonal/genetic/imaging workup, azoospermia (OA vs NOA), medical and surgical management, varicocele, ART, and vasectomy.